Eating plain Greek yogurt regularly is linked to lower levels of inflammation markers in the blood, which may help reduce the risk of chronic diseases, but this effect is not proven and may depend on avoiding added sugars.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review would determine whether Greek yogurt specifically reduces systemic inflammation markers more than other foods or placebo in RCTs.
A systematic review and meta-analysis of at least 12 RCTs comparing daily consumption of 200g plain Greek yogurt (≥10g protein, ≤2g sugar) versus isocaloric control (e.g., fruit or grain-based snack) for 8–16 weeks in adults with elevated baseline CRP (>3 mg/L), measuring serum CRP, TNF-α, and IL-6 as primary endpoints.
An RCT would establish whether Greek yogurt directly lowers systemic inflammation markers compared to a control.
A double-blind RCT with 100 adults aged 40–65 with elevated CRP (>3 mg/L) randomized to consume 200g of standardized plain Greek yogurt (verified CFU count, ≤2g sugar) or a matched placebo (maltodextrin-based snack) daily for 12 weeks, with primary outcomes being serum CRP (ELISA), TNF-α, and IL-6 (multiplex assay) measured at baseline, 6, and 12 weeks.
A cohort study would determine whether habitual Greek yogurt intake predicts lower systemic inflammation over time in a general population.
A prospective cohort of 4,000 adults aged 30–70 tracking weekly Greek yogurt intake (brand, sugar content, CFU) over 5 years, with annual measurements of serum CRP, TNF-α, and IL-6, adjusting for BMI, smoking, physical activity, and fiber intake.
A cross-sectional study would identify whether regular Greek yogurt consumers have lower inflammatory markers than non-consumers at a single time point.
A cross-sectional analysis of 2,000 adults measuring daily Greek yogurt intake (via food frequency questionnaire) and comparing serum CRP, TNF-α, and IL-6 levels between consumers (≥3 servings/week) and non-consumers, adjusting for age, sex, BMI, and dietary fiber.
A case series could document individual inflammatory responses to Greek yogurt in people with chronic inflammatory conditions.
A case series of 10 individuals with metabolic syndrome consuming 200g plain Greek yogurt daily for 8 weeks, with pre- and post-intervention serum CRP, TNF-α, and IL-6 measurements and gut microbiome profiling.